title: Phase two steroid metabolism and its roles in breast and prostate cancer patients.
abstract: Breast and prostate cancer are diseases in which steroids and steroid metabolism could markedly influence clinical outcomes for patients. In both malignancies the modification of ketone and hydroxyl groups attached to the steroid backbone (phase one metabolism) has been examined in detail but the conjugation reactions (phase two metabolism) have not been extensively studied. Therefore, in this review we aim to summarize phase two metabolism in breast and prostate cancers from a number of perspectives, including the impact of variation in serum levels of conjugated steroids, tissue, and pathology specific expression of phase two enzymes, and consequences of genetic variations of these conjugation enzymes. In addition to this biological perspective, we will also address current pharmacological efforts to manipulate phase two metabolism as a potential therapy for hormone dependent cancers, including clinical trials of STS inhibitors and preclinical STS inhibitor development. While this review is not intended to cover any one particular area in great technical depth, it is intended as an introduction to and/or update on the importance of variance in phase two metabolic pathways in breast and prostate cancers.
authors.affiliation: Department of Pathology, Tohoku University School of Medicine, Miyagi , Sendai , Japan.
authors.forename: Keely M
authors.initials: KM
authors.lastname: McNamara
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Nakamura
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Miki
authors.forename: Hironobu
authors.initials: H
authors.lastname: Sasano
keywords: STS inhibition; breast; cancer; intracrinology; prostate
references.citation: Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1937-43
references.pmid: 21750172
references.citation: Clin Cancer Res. 2006 Mar 1;12(5):1585-92
references.pmid: 16533785
references.citation: Cancer Res. 2003 Jun 1;63(11):2762-70
references.pmid: 12782580
references.citation: J Natl Cancer Inst. 2008 Feb 6;100(3):170-83
references.pmid: 18230794
references.citation: J Cancer Res Clin Oncol. 2008 Jan;134(1):67-73
references.pmid: 17661084
references.citation: J Pharmacol Exp Ther. 2011 Nov;339(2):597-606
references.pmid: 21828262
references.citation: Endocr Relat Cancer. 2005 Dec;12(4):1071-82
references.pmid: 16322344
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1090-5
references.pmid: 15894657
references.citation: Breast Cancer Res Treat. 2005 Jun;91(3):249-58
references.pmid: 15952058
references.citation: Br J Cancer. 2004 Jan 12;90(1):153-9
references.pmid: 14710223
references.citation: Eur J Endocrinol. 1998 Apr;138(4):421-4
references.pmid: 9578510
references.citation: Endocr Rev. 2009 Jun;30(4):343-75
references.pmid: 19389994
references.citation: Breast Cancer Res Treat. 2007 Dec;106(2):215-27
references.pmid: 17268815
references.citation: J Clin Endocrinol Metab. 2012 Mar;97(3):E428-32
references.pmid: 22170718
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):537-46
references.pmid: 20142249
references.citation: J Natl Cancer Inst. 1998 Sep 2;90(17):1292-9
references.pmid: 9731736
references.citation: J Steroid Biochem Mol Biol. 1995 Dec;55(3-4):395-403
references.pmid: 8541236
references.citation: J Clin Endocrinol Metab. 2007 Dec;92(12):4878-82
references.pmid: 17698910
references.citation: Mol Cancer Ther. 2008 Aug;7(8):2435-44
references.pmid: 18723489
references.citation: Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):259-70
references.pmid: 18471784
references.citation: Breast Cancer Res Treat. 2010 Apr;120(3):639-48
references.pmid: 20151319
references.citation: Int J Cancer. 2007 Jan 15;120(2):285-91
references.pmid: 17066438
references.citation: Ann N Y Acad Sci. 2009 Feb;1155:88-98
references.pmid: 19250196
references.citation: J Clin Endocrinol Metab. 1986 May;62(5):812-5
references.pmid: 2937801
references.citation: Steroids. 2012 Jun;77(7):719-26
references.pmid: 22503713
references.citation: Breast Cancer Res. 2005;7(6):R909-21
references.pmid: 16280036
references.citation: J Clin Endocrinol Metab. 2007 Sep;92(9):3697-704
references.pmid: 17579197
references.citation: J Steroid Biochem Mol Biol. 2011 May;125(1-2):39-45
references.pmid: 21356310
references.citation: Cancer Chemother Pharmacol. 2011 Jun;67(6):1341-52
references.pmid: 20737149
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2013 May 15;927:22-36
references.pmid: 23317577
references.citation: Expert Opin Ther Pat. 2013 Jan;23(1):79-98
references.pmid: 23136854
references.citation: J Natl Cancer Inst. 2002 Apr 17;94(8):606-16
references.pmid: 11959894
references.citation: Biochem Biophys Res Commun. 2001 Oct 19;288(1):280-9
references.pmid: 11594786
references.citation: Anticancer Res. 2006 Nov-Dec;26(6C):4985-90
references.pmid: 17214375
references.citation: J Steroid Biochem Mol Biol. 2009 Feb;113(3-5):195-201
references.pmid: 19159687
references.citation: Cancer Res. 2000 Feb 15;60(4):950-6
references.pmid: 10706110
references.citation: Genet Test Mol Biomarkers. 2013 Jan;17(1):3-9
references.pmid: 23098242
references.citation: Prostate. 2009 Jun 1;69(8):895-907
references.pmid: 19267353
references.citation: Mol Hum Reprod. 1999 Nov;5(11):995-1002
references.pmid: 10541560
references.citation: J Biol Chem. 2013 Mar 22;288(12):8619-8626
references.pmid: 23362278
references.citation: Breast Cancer Res. 2004;6(3):R252-63
references.pmid: 15084249
references.citation: J Natl Cancer Inst Monogr. 2000;(27):113-24
references.pmid: 10963623
references.citation: J Clin Endocrinol Metab. 1984 Sep;59(3):417-21
references.pmid: 6746859
references.citation: Mol Cell Endocrinol. 2011 Jul 4;340(2):148-53
references.pmid: 21073915
references.citation: Prostate. 2011 Jun 15;71(9):909-14
references.pmid: 21541968
references.citation: J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):301-10
references.pmid: 9699884
references.citation: J Steroid Biochem Mol Biol. 2003 Feb;84(2-3):343-9
references.pmid: 12711021
references.citation: Breast Cancer Res Treat. 2007 Aug;104(2):211-9
references.pmid: 17061037
references.citation: J Endocrinol. 2012 Feb;212(2):99-110
references.pmid: 21859802
references.citation: Endocrinology. 1952 Jun;50(6):587-99
references.pmid: 12980068
references.citation: J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):247-53
references.pmid: 18467088
references.citation: Cancer Res. 1999 Jan 15;59(2):377-81
references.pmid: 9927050
references.citation: Cancer Detect Prev. 2006;30(3):262-8
references.pmid: 16859836
references.citation: J Clin Endocrinol Metab. 2011 Sep;96(9):E1550-7
references.pmid: 21733997
references.citation: Breast Cancer Res Treat. 2004 Jun;85(3):239-45
references.pmid: 15111762
references.citation: J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):181-5
references.pmid: 17933521
references.citation: J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):214-21
references.pmid: 17055258
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1473-8
references.pmid: 16896035
references.citation: Drug Metab Rev. 2010 Feb;42(1):99-109
references.pmid: 20070244
references.citation: J Steroid Biochem Mol Biol. 2013 Jan;133:66-76
references.pmid: 22982153
references.citation: J Clin Endocrinol Metab. 1996 Apr;81(4):1460-4
references.pmid: 8636351
references.citation: J Clin Endocrinol Metab. 1988 Jan;66(1):212-6
references.pmid: 3335605
references.citation: Nat Rev Cancer. 2010 Mar;10(3):205-12
references.pmid: 20147902
references.citation: Drug Metab Dispos. 2009 Jan;37(1):32-40
references.pmid: 18838504
references.citation: Breast Cancer Res Treat. 2008 Jul;110(2):367-76
references.pmid: 17909964
references.citation: Hum Mutat. 2009 Sep;30(9):1310-9
references.pmid: 19572376
references.citation: Br J Pharmacol. 2003 Aug;139(8):1373-82
references.pmid: 12922923
references.citation: Biochem J. 1948;43(2):231-4
references.pmid: 16748393
references.citation: Cancer Detect Prev. 2007;31(4):310-5
references.pmid: 17935910
references.citation: Prostate. 2006 Jun 15;66(9):1005-12
references.pmid: 16541422
references.citation: J Steroid Biochem Mol Biol. 2013 Sep;137:183-98
references.pmid: 23391659
references.citation: Clin Cancer Res. 2006 Sep 15;12(18):5543-9
references.pmid: 17000691
references.citation: J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65
references.pmid: 15601642
references.citation: Chem Biol Interact. 1998 Feb 20;109(1-3):3-27
references.pmid: 9566730
references.citation: Mol Endocrinol. 2012 Aug;26(8):1252-67
references.pmid: 22745190
references.citation: J Biol Chem. 1998 May 1;273(18):10888-92
references.pmid: 9556564
references.citation: Breast Cancer Res Treat. 2013 Jun 25;140(1):73-82
references.pmid: 23797179
references.citation: Horm Cancer. 2013 Feb;4(1):1-11
references.pmid: 23096432
references.citation: Cancer Sci. 2012 Jun;103(6):1000-9
references.pmid: 22380844
references.citation: J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):449-54
references.pmid: 14623543
references.citation: Lancet. 1992 Apr 11;339(8798):887-9
references.pmid: 1348296
references.citation: Trends Endocrinol Metab. 2003 Dec;14(10):473-9
references.pmid: 14643063
references.citation: J Chromatogr A. 2001 Nov 23;935(1-2):267-78
references.pmid: 11762779
references.citation: Int J Cancer. 1995 Sep 27;63(1):106-11
references.pmid: 7558436
references.citation: Int J Cancer. 2009 Dec 1;125(11):2687-96
references.pmid: 19551860
references.citation: Breast Cancer Res. 2007;9(1):R7
references.pmid: 17244352